Fund · FlexShares Ultra-Short Income Fund · measured from SEC filings
RAVI holdings
RAVI reports 246 holdings and behaves like 116.8 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-07-31. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.
Measured concentration
as of 2026-07-31Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 0% at a quoted market price (level 1), 16 issuer countries, 24.32% restricted securities.
What stands out
as of 2026-07-31RAVI's largest investment is Federal National Mortgage Association Discount at 2.92% of net assets. Walt Disney Co. (the) and Merck & Co. Inc follow; the three together are 7.64%. Ten companies are 18.78% of the fund; the other 236 share the rest. Among the 192 bond funds measured here, RAVI behaves like 116.8 holdings against a median of 236.4 — 2.0 times more concentrated than the median. Across 27 quarterly filings RAVI has held roughly steady since 2019-10-31 (131.9 then, 134.1 now). Between the 2026-01-31 and 2026-04-30 filings 41 positions were added and 49 dropped; 21.0% of the weight moved. the United States is the largest country at 73.94% of the portfolio, across 16 countries in the filing.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable bond funds on this site. Nothing here is a view on the fund.
Every filing since 2019
27Between 2019-10-31 and 2026-04-30, RAVI went from behaving like 131.9 equally weighted positions to 134.1 — 2% more, while its top ten went from 14.98% to 17.48% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-04-30 | 248 | 134.1 | 17.48% | 2.94% |
| 2026-01-31 | 256 | 155.5 | 14.45% | 1.97% |
| 2025-10-31 | 268 | 164.9 | 12.89% | 2.37% |
| 2025-07-31 | 266 | 172.9 | 11.26% | 1.82% |
| 2025-04-30 | 254 | 160.1 | 11.89% | 2.24% |
| 2025-01-31 | 273 | 176.1 | 10.61% | 1.22% |
| 2024-10-31 | 284 | 180.3 | 10.45% | 1.31% |
| 2024-07-31 | 290 | 187 | 9.8% | 1.29% |
Earlier filings (19 more, back to 2019-10-31)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-04-30 | 316 | 198.6 | 9.44% | 1.31% |
| 2024-01-31 | 331 | 213.5 | 8.72% | 0.9% |
| 2023-10-31 | 330 | 196.6 | 11.41% | 1.88% |
| 2023-07-31 | 325 | 151 | 17.94% | 2.01% |
| 2023-04-30 | 333 | 133.8 | 19.36% | 3.28% |
| 2023-01-31 | 348 | 132.4 | 20.06% | 3.31% |
| 2022-10-31 | 339 | 111 | 20.78% | 4.69% |
| 2022-07-31 | 349 | 134.8 | 14.77% | 5.44% |
| 2022-04-30 | 359 | 198.5 | 11.69% | 1.56% |
| 2022-01-31 | 311 | 147.7 | 14.65% | 4.15% |
| 2021-10-31 | 269 | 167.8 | 12.08% | 1.56% |
| 2021-07-31 | 262 | 166.1 | 11.87% | 1.52% |
| 2021-04-30 | 275 | 178.9 | 11.12% | 1.43% |
| 2021-01-31 | 300 | 193 | 10.65% | 1.32% |
| 2020-10-31 | 295 | 165.8 | 13.02% | 3.22% |
| 2020-07-31 | 289 | 125.3 | 14.49% | 5.74% |
| 2020-04-30 | 260 | 156.2 | 13.55% | 2.69% |
| 2020-01-31 | 253 | 158.5 | 12.83% | 2.37% |
| 2019-10-31 | 244 | 131.9 | 14.98% | 4.35% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
Largest positions, as filed
as of 2026-04-30The 15 largest of 246 positions in RAVI's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: RAVI.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | FNMA | 2.94% | 2.9% |
| 2 | Walt Disney Co. (The) | 2.78% | 5.7% |
| 3 | Merck & Co., Inc. | 1.97% | 7.7% |
| 4 | Bank of America Corp. | 1.73% | 9.4% |
| 5 | Abbott Laboratories | 1.66% | 11.1% |
| 6 | AT&T, Inc. | 1.64% | 12.7% |
| 7 | Truist Bank | 1.29% | 14.0% |
| 8 | Chevron USA, Inc. | 1.24% | 15.3% |
| 9 | Sanofi SA | 1.20% | 16.4% |
| 10 | Australia & New Zealand Banking Group Ltd. | 1.03% | 17.5% |
| 11 | Toyota Motor Credit Corp. | 1.00% | 18.5% |
| 12 | Macquarie Bank Ltd. | 0.94% | 19.4% |
| 13 | Sanofi SA | 0.90% | 20.3% |
| 14 | BlackRock Funding, Inc. | 0.88% | 21.2% |
| 15 | Allstate Corp. (The) | 0.88% | 22.1% |
By country of issuer
as of 2026-04-30Share of RAVI's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| United States | 74.07% |
| Canada | 5.52% |
| United Kingdom | 4.55% |
| France | 4.44% |
| Australia | 3.52% |
| Japan | 2.06% |
| Sweden | 1.05% |
| Germany | 1.03% |
Returns the fund reported
2019-08 – 2026-04Monthly total returns from Item B.5 of RAVI's own filings, 81 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference 0.03 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: RAVI.json · all funds.
Since the previous filing
2026-01-31 → 2026-04-30256 positions became 248: 41 added (20.8% of the fund at the later date), 49 dropped (17.0% at the earlier date). Half the sum of all weight changes, a turnover proxy: 21.0%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of RAVI compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-01-31 | 2026-04-30 | Largest decreases | 2026-01-31 | 2026-04-30 |
|---|---|---|---|---|---|
| United States of America | 0.36% | 0.38% | Eli Lilly & Co. | 1.23% | 0.51% |
| CNH Industrial Capital LLC | 0.73% | 0.74% | Chevron USA, Inc. | 1.60% | 1.24% |
| VMware LLC | 0.67% | 0.68% | Mastercard, Inc. | 0.85% | 0.49% |
| Sumisho Air Lease Corp. | 0.77% | 0.78% | United States of America | 0.36% | 0.07% |
| Merck & Co., Inc. | 1.97% | 1.97% | PayPal Holdings, Inc. | 0.59% | 0.34% |
| AT&T, Inc. | 1.64% | 1.64% | Walmart, Inc. | 0.68% | 0.47% |
New: FNMA (2.94%), Walt Disney Co. (The) (2.78%), Abbott Laboratories (1.66%), Exelon Corp. (0.81%), AbbVie, Inc. (0.79%), Eaton Corp. (0.75%). Gone: FNMA (1.36%), Williams Cos., Inc. (The) (1.00%), Kellanova (0.86%), Oracle Corp. (0.79%), Elevance Health, Inc. (0.75%), Intel Corp. (0.73%).
Asset categories and pricing
as of 2026-07-31| Asset category (as filed) | Share of investments |
|---|---|
| debt DBT | 83.62% |
| ABS-O ABS-O | 6.39% |
| mortgage-backed ABS-MBS | 5.05% |
| short-term investment STIV | 4.95% |
0.0% of RAVI is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.
Neighbours by effective holdings, debt funds
10Every measured debt fund lined up by how many holdings it behaves like; these sit either side of RAVI (116.8). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| HFSI Hartford Strategic Income ETF | 1,179 | 104.1 * | 24.1% | 2026-07-31 |
| FPEI First Trust Institutional Preferred Securities and Income ETF | 174 | 106.7 | 17.96% | 2026-07-31 |
| FALN iShares Fallen Angels USD Bond ETF | 159 | 109.6 | 17.8% | 2026-07-31 |
| FREI Fidelity Real Estate Income Fund | 589 | 115.9 | 18.31% | 2026-07-31 |
| LDUR PIMCO Enhanced Low Duration Active Exchange-Traded Fund | 791 | 116.3 * | 18.44% | 2026-06-30 |
| ISHG iShares 1-3 Year International Treasury Bond ETF | 187 | 120.4 | 14.73% | 2026-07-31 |
| TAGG T. Rowe Price QM U.S. Bond ETF | 1,817 | 125.9 | 20.44% | 2026-07-31 |
| WIP State Street(R) SPDR(R) FTSE International Government Inflation-Protected Bond ETF | 179 | 126 | 15.12% | 2026-06-30 |
| CORB AB Core Bond ETF | 705 | 131.5 | 21.09% | 2026-05-31 |
| BSJS Invesco BulletShares 2028 High Yield Corporate Bond ETF | 193 | 137.7 | 15.77% | 2026-05-31 |
Essays that examine RAVI
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.